Category
Sub-Saharan Africa
Access, financing and health system capacity across sub-Saharan Africa. This coverage follows procurement, donor funding, local manufacturing and the HTA capacity being built across the region.
298 articles in this topic.
Articles in this category

11/18/2026
FDA Launches Global Reliance Disclosure Program for Approval Packages
The FDA's Global Reliance Disclosure Program lets companies pass minimally redacted approval packages to regulators outside the US. Lenacapavir is the launch case, and the FDA intends to widen the program in January 2027. #SyenzaNews #MarketAccess
Read Article →
11/17/2026
Three-Month Dapivirine Vaginal Ring Receives Positive EMA Opinion
The three-month dapivirine vaginal ring has received a positive EMA scientific opinion, with the ring replaced four times per year. #SyenzaNews #HIVprevention #MarketAccess
Read Article →
11/13/2026
NHLS Governance Crisis Reaches Parliament With R1.8 Billion in Irregular Spending
The NHLS governance crisis reached Parliament with R1.8 billion in irregular spending, an interim board and a disputed IP Capital consultancy.
Read Article →
11/13/2026
SADC Pharmaceutical Pooled Procurement Charter Signed in Durban
The Charter establishing the SADC Pharmaceuticals Pooled Procurement Services was signed in Durban on 12 November 2026, with Tanzania the first Member State to sign. #SyenzaNews #MarketAccess
Read Article →
11/12/2026
Aspen Gets Approval for Generic Semaglutide in Brazil and South Africa
Aspen Pharmacare has received approval for generic semaglutide in Brazil and South Africa, following Canada in July. Launches in all three markets are expected over the coming months. #SyenzaNews #MarketAccess
Read Article →
11/10/2026
Enzutrix Patent Dispute Heads to Constitutional Court: Hearing Set for 23 November
The Enzutrix patent dispute goes to South Africa's Constitutional Court on 23 November 2026. UC and Astellas are pursuing damages over the generic prostate cancer drug, while Eurolab argues the patent was never validly obtained. #SyenzaNews #MarketAccess
Read Article →
11/3/2026
Global Drug Regulators Summit in Seoul Takes Up AI and Animal Testing Alternatives
The Ministry of Food and Drug Safety hosts ICMRA, the international coalition of medicines regulators, in Seoul from 3 to 6 November 2026, with AI rules and alternatives to animal testing on the agenda. #SyenzaNews #MarketAccess #drugregulation
Read Article →
11/3/2026
Generic lenacapavir HIV prevention gets FDA tentative approval
Dr. Reddy's has FDA tentative approval for generic lenacapavir HIV prevention, priced at US$40 per person per year across 120 countries. #SyenzaNews #HIVprevention #MarketAccess
Read Article →
10/26/2026
Antiretroviral Tender Awards Declared Invalid by Pretoria Court
A Pretoria court has declared invalid the antiretroviral tender awards for two items and ordered the health department to redo the split within 120 days. Cipla's review succeeded on all five grounds, while Hetero's challenge was dismissed with attorney-and-client costs. #SyenzaNews #SouthAfrica #HIV
Read Article →
10/8/2026
FuturePHARMA Targets Local Pharmaceutical Manufacturing in South Africa
The CSIR FuturePHARMA facility in Tshwane aims to turn South African research into medicines made locally.
Read Article →
9/24/2026
South Africa Approves Second Single Exit Price Adjustment for 2026
South Africa has set a second single exit price adjustment for 2026, lifting listed medicine prices by 2.88% from 1 October. #SyenzaNews #MarketAccess #Pharma
Read Article →
9/22/2026
SAHPRA Annual Report: Clean Audit and WHO ML3 Vaccine Milestone
SAHPRA reports a clean audit, WHO ML3 vaccine maturity, and ICH membership in its 2025/26 annual report, with R515.7 million in revenue and a R33.7 million surplus. #SyenzaNews #MarketAccess #SAHPRA
Read Article →

